Ovarian Cancer Panel
View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures| Panel Member | Clinical Research Support | Advisory Boards, Speakers Bureau, Expert Witness, or Consultant | Patent, Equity, or Royalty | Other | Date Completed |
|---|---|---|---|---|---|
Ronald D. Alvarez, MD |
None |
Eli Lilly and Company; |
None |
None |
9/28/2009 |
Deborah K. Armstrong, MD |
None |
Celgene Corporation; |
None |
None |
7/17/2009 |
Barry Boston, MD |
BEST |
Bayer HealthCare; |
None |
None |
10/28/2009 |
Robert Burger, MD, FACOG, FACS |
Pending |
||||
Lee-may Chen, MD |
AstraZeneca Pharmaceuticals LP |
None |
None |
None |
7/6/2009 |
Larry Copeland, MD |
Eli Lilly and Company; |
Bayer HealthCare; |
None |
Gynecologic Oncology Group |
10/2/2009 |
Marta Ann Crispens, MD |
None |
None |
None |
None |
10/13/2009 |
Mary Dwyer Rosario, MS |
None |
None |
None |
None |
7/1/2009 |
David K. Gaffney, MD, PhD |
None |
None |
None |
None |
9/28/2009 |
Lauren Gallagher, PhD |
None |
None |
None |
None |
8/28/2009 |
David M Gershenson, MD |
AstraZeneca Pharmaceuticals LP; |
National Cancer Institute |
Abbott Laboratories; |
None |
9/28/2009 |
Benjamin E. Greer, MD |
None |
None |
None |
None |
11/16/2009 |
Kristina M Gregory, RN, MSN, OCN |
None |
None |
None |
None |
8/21/2009 |
Perry W. Grigsby, MD, MS, MBA |
None |
None |
None |
None |
7/1/2009 |
Laura J. Havrilesky, MD |
None |
BD-TriPath Oncology; |
None |
None |
10/6/2009 |
Miranda Hughes, PhD |
None |
None |
Myriad Genetic Laboratories, Inc.; |
None |
7/21/2009 |
Carolyn Johnston, MD |
None |
None |
None |
american cancer society-great lakes division; |
7/8/2009 |
Johnathan M. Lancaster, MD, PhD |
ImClone Systems Incorporated; |
Amgen Inc.; |
None |
None |
9/29/2009 |
Shashikant Lele, MD |
None |
None |
None |
None |
8/21/2009 |
Maurie Markman, MD |
None |
Amgen Inc.; |
None |
None |
7/16/2009 |
Ursula A. Matulonis, MD |
AstraZeneca Pharmaceuticals LP; |
Eisai Inc.; |
None |
None |
10/9/2009 |
Joan S McClure, MS |
None |
None |
None |
None |
9/28/2009 |
Robert J. Morgan, MD, FACP |
NIH-CTEP |
None |
Abbott Laboratories |
None |
7/1/2009 |
David M. O'Malley, MD |
None |
Eli Lilly and Company; |
None |
None |
7/2/2009 |
Richard T. Penson, MD, MRCP |
Berlex Inc.; |
None |
None |
None |
7/21/2009 |
Steven W. Remmenga, MD |
None |
None |
None |
None |
9/28/2009 |
Paul Sabbatini, MD |
None |
Boehringer Ingelheim GmbH; |
None |
None |
9/1/2009 |
Russell J. Schilder, MD |
None |
None |
None |
None |
7/2/2009 |
Julian C Schink, MD |
None |
None |
None |
None |
9/28/2009 |
Nelson Teng, MD, PhD |
GOG |
None |
None |
None |
11/16/2009 |